Dewleen G. Baker mainly focuses on Psychiatry, Internal medicine, Anxiety disorder, Endocrinology and Cerebrospinal fluid. His Psychiatry research is multidisciplinary, incorporating elements of Odds ratio and Clinical psychology. Internal medicine is often connected to Gastroenterology in his work.
His work deals with themes such as Anesthesia, Arousal and Provocation test, which intersect with Anxiety disorder. His Endocrinology study integrates concerns from other disciplines, such as Crossover study and Anxiety. His Cerebrospinal fluid research focuses on Norepinephrine and how it relates to Psychoneuroimmunology, Interleukin 6, Pathophysiology, Circadian rhythm and Analysis of variance.
His primary scientific interests are in Psychiatry, Internal medicine, Clinical psychology, Endocrinology and Posttraumatic stress. His Mental health and Depression study in the realm of Psychiatry interacts with subjects such as Injury prevention. The various areas that Dewleen G. Baker examines in his Depression study include Quality of life, Aggression and Anxiety.
His work in the fields of Cerebrospinal fluid overlaps with other areas such as Neuropeptide Y receptor. His studies in Cerebrospinal fluid integrate themes in fields like Anesthesia, Homovanillic acid, Interleukin 6, Central nervous system and Serotonergic. His Clinical psychology study deals with Cohort intersecting with Cohort study and Genome-wide association study.
Clinical psychology, Epigenetics, Genetics, Cohort and DNA methylation are his primary areas of study. His Clinical psychology research includes themes of Psychological intervention, Depression and Risk factor. His Cohort research is multidisciplinary, incorporating perspectives in Posttraumatic stress, Traumatic brain injury, Mental health, Mental illness and Amygdala.
The concepts of his Posttraumatic stress study are interwoven with issues in Polygenic risk score and Traumatic stress. Dewleen G. Baker has included themes like Internal medicine and Oncology in his Epigenome study. His Anxiety study introduces a deeper knowledge of Psychiatry.
Dewleen G. Baker mainly investigates Internal medicine, Neuroscience, Clinical psychology, Immune dysregulation and Heritability. Dewleen G. Baker has researched Internal medicine in several fields, including Endocrinology, Epigenetics and Oncology. His Clinical psychology research incorporates themes from Cohort study, Anhedonia and Anxiety.
His study in Immune dysregulation is interdisciplinary in nature, drawing from both Combat stress reaction, Interleukin 6, Chronic stress, Systemic inflammation and Circadian rhythm. His research investigates the link between Heritability and topics such as Genetic variation that cross with problems in Genetic association, Risk factor, Posttraumatic stress and Genetic risk. As part of the same scientific family, Dewleen G. Baker usually focuses on Posttraumatic stress, concentrating on Cohort and intersecting with Genome-wide association study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial.
Kathleen Brady;Teri Pearlstein;Gregory M. Asnis;Dewleen Baker.
JAMA (2000)
Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder.
Dewleen G. Baker;Scott A. West;Wendall E. Nicholson;Nosa N. Ekhator.
American Journal of Psychiatry (1999)
CSF norepinephrine concentrations in posttraumatic stress disorder.
Thomas D. Geracioti;Dewleen G. Baker;Nosakhare N. Ekhator;Scott A. West.
American Journal of Psychiatry (2001)
Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting
Matthew J. Friedman;Charles R. Marmar;Dewleen G. Baker;Carolyn R. Sikes.
The Journal of Clinical Psychiatry (2007)
Corticotropin-releasing hormone in depression and post-traumatic stress disorder
J.W. Kasckow;D. Baker;T.D. Geracioti.
Peptides (2001)
Post-Traumatic Stress Disorder and Smoking: A Systematic Review
Steven S. Fu;Miles McFall;Andrew J. Saxon;Jean C. Beckham.
Nicotine & Tobacco Research (2007)
Largest GWAS of PTSD (N=20 070) yields genetic overlap with schizophrenia and sex differences in heritability
L. E. Duncan;A. Ratanatharathorn;A. E. Aiello;L. M. Almli.
Molecular Psychiatry (2018)
Assessment of Plasma C-Reactive Protein as a Biomarker of Posttraumatic Stress Disorder Risk
Satish A. Eraly;Satish A. Eraly;Caroline M. Nievergelt;Caroline M. Nievergelt;Adam X. Maihofer;Donald A. Barkauskas.
JAMA Psychiatry (2014)
Plasma and cerebrospinal fluid interleukin-6 concentrations in posttraumatic stress disorder.
Dewleen G. Baker;Nosa N. Ekhator;John W. Kasckow;Kelly K. Hill.
Neuroimmunomodulation (2001)
Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial.
Miles McFall;Andrew J. Saxon;Carol A. Malte;Bruce Chow.
JAMA (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of California, San Diego
Harvard University
Leiden University Medical Center
Icahn School of Medicine at Mount Sinai
Harvard University
University of California, San Diego
University of California, San Diego
University of California, San Diego
Boston University
Duke University
University of California, San Diego
North Carolina State University
Shanghai Jiao Tong University
New York University
Inserm : Institut national de la santé et de la recherche médicale
Monterrey Institute of Technology and Higher Education
MSD (United States)
University of Würzburg
University of Western Australia
University of Wisconsin–Madison
Langley Research Center
University of Siena
Radboud University Nijmegen
The University of Texas MD Anderson Cancer Center
Chung-Ang University
Duke University